Tumor-specific Th17-polarized cells eradicate large established melanoma - sprookjes - yvandenbroek - TriplyDB

Tumor-specific Th17-polarized cells eradicate large established melanoma

Tumor-specific Th17-polarized cells eradicate large established melanoma

http://www.wikidata.org/entity/Q24648032

about

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells IL-17RC: a partner in IL-17 signaling and beyond Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma T helper 17 cells promote cytotoxic T cell activation in tumor immunity Balancing Inflammation: The Link between Th17 and Regulatory T Cells The interplay between the microbiome and the adaptive immune response in cancer development Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses Melanoma: oncogenic drivers and the immune system CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression New perspectives on the role of vitiligo in immune responses to melanoma Reciprocal relationship between myeloid-derived suppressor cells and T cells Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses Novel immunotherapies for hematologic malignancies Diversity of IL-17-producing T lymphocytes The role and regulation of human Th17 cells in tumor immunity Th17 Cell Plasticity and Functions in Cancer Immunity Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease.Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance IL-17 mediated inflammation promotes tumor growth and progression in the skin Prospective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patients Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.The tyrosine phosphatase SHP-1 dampens murine Th17 development.Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice.Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance.β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity.Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer.High IL-17 expression is associated with an unfavorable prognosis in thyroid cancer

P2860

Q21131200-EEEFE04C-1AD0-42C7-8F0D-B14B2C39ACE4 Q24601213-9E74C2A3-1A71-4D5D-8276-970DA614CC77 Q24629783-D0A09844-5B0E-438D-91F0-13BDF66606E3 Q24629841-5E1F1D29-A6DE-4B5B-9F6E-C8EC6695F42E Q24646584-44647E0D-93FF-415D-800F-6C495A2971B8 Q26740440-DFB44E7E-C0D7-489A-8CCC-05018E2BC4B8 Q26745703-414A3D4D-F38A-4E04-8C02-F583EDB87C0C Q26746887-6FDA7D24-3BF2-4DF3-B9C2-F1FCF228B249 Q26775598-0DDCEF2E-5672-49E0-A68E-BAEEC5B87DB2 Q26782520-E18D5677-5327-475F-952C-0CB055D24F0A Q26795540-ABCC1CBE-8A5A-45BF-AABB-0D88FAA80DE9 Q26801436-1DC06E88-B7B6-4DB3-A27C-B227F40AF431 Q26996799-80ACD07B-6E9F-40D8-9B0A-37BC730158E5 Q27000664-CFF64E25-B647-4F8D-A081-7DC3EB7F2A2F Q27001081-480EC1E7-E25F-492E-8BB9-448AA25EA39F Q27004436-AF137E2B-D6FD-4B36-AF4B-2331F2B589F8 Q27010199-CDA57DA4-AD3B-42ED-8BB8-E6E0D349AAA1 Q27011396-B7D15356-8307-464D-AB06-0DA09E0B200A Q27012901-D3DADE02-E123-41C9-80FC-116126357BB9 Q27334727-A529CEB3-1005-4C6C-A236-65063A10F698 Q27687830-204F685A-7AD0-471C-947A-8EDF5F6B4370 Q28066522-0661D7F6-651C-4193-A1D0-F0D9203EA383 Q28075992-102CC8F6-2192-43EB-88A6-ADF98139E2CF Q28246944-D61B6A5E-F1CE-49B1-BC9C-801686AEBE68 Q28387629-A966DB13-DDEF-4CF6-8B28-16AAE4948D23 Q28388093-C2A1CD3D-1277-4333-932C-9FCCE398A4F1 Q28480915-CC61477F-AD2A-41E9-A240-EF9B0BEC3376 Q28542660-8D28FDE2-200F-49C3-8C0D-4E34F5A8E4D2 Q30371711-8B1B66E6-0400-492E-8E40-8A89AA7748A8 Q30419341-DF02D192-652A-42C7-9A6E-B567716E7871 Q30433217-7772EAA0-C846-4188-AB4B-CC82755253A2 Q30583272-4BFAA48D-CC15-4F0A-9A40-E5656AE46337 Q30667174-820B22B6-1CEA-4CE3-A4F4-5C6713D34E8A Q33509292-AFAB26AA-CA9F-4EDC-B66D-43B45F656A96 Q33527427-0806418A-BDF4-4CD1-B97C-B86126B582E7 Q33530527-6054B59E-0DD9-45DB-9B78-0486C056E0D6 Q33569842-4E7CAB74-2568-4DDE-92CA-5DA26D4F0266 Q33578997-18F58E6B-8FBE-43CB-8964-1A1705B56A29 Q33582300-4463FDC7-AE8B-4189-9F63-774D0209B558 Q33597831-4D195D39-1988-48C0-8139-AF915D11E746

P2860

Tumor-specific Th17-polarized cells eradicate large established melanoma

http://www.wikidata.org/entity/Q24648032

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Tumor-specific Th17-polarized cells eradicate large established melanoma

@ast

Tumor-specific Th17-polarized cells eradicate large established melanoma

@en

Tumor-specific Th17-polarized cells eradicate large established melanoma

@nl

type

label

Tumor-specific Th17-polarized cells eradicate large established melanoma

@ast

Tumor-specific Th17-polarized cells eradicate large established melanoma

@en

Tumor-specific Th17-polarized cells eradicate large established melanoma

@nl

prefLabel

Tumor-specific Th17-polarized cells eradicate large established melanoma

@ast

Tumor-specific Th17-polarized cells eradicate large established melanoma

@en

Tumor-specific Th17-polarized cells eradicate large established melanoma

@nl

P1433

Q24648032-B9F938F8-64D4-4A01-B7AC-A65F8F923818

P1476

Q24648032-58631AA1-EA94-476E-8DE2-E644112A9A0A

P2093

Q24648032-0EFD76D0-9583-422A-A64C-C8C96D769D3E

Q24648032-322A2AB6-7B36-46EE-9053-2744EE88AC48

Q24648032-35A30728-3F17-45D3-99B1-80D412ED6152

Q24648032-47E02EA4-2F61-4939-A68B-CC4E78325CE4

Q24648032-525FE305-E0AF-4842-B799-3A1690BA94FB

Q24648032-539E8D97-21C8-4AD3-A9A5-F7ADA37CC9C3

Q24648032-5A5A5929-9EC3-47A5-9BD5-C85FBAE68FB4

Q24648032-6251110F-7F94-41CE-A938-9F6A5C1C284D

Q24648032-6C925F05-59F9-45BF-AA9F-E178BCA04178

Q24648032-73FC337F-2888-4965-97B8-26F711CBDED3

P2860

Q24648032-0026190A-5963-4990-AB65-160E186AC8C4

Q24648032-033DE240-C0B1-45FB-980E-3AF6C65F8A3E

Q24648032-03ACBFC8-35F9-42C5-809D-C37321D85764

Q24648032-07BD4CDE-7C44-4B2D-B8F8-25E99927D77E

Q24648032-14D886CD-24F7-4B2C-921F-8EC0D3F73318

Q24648032-176CB1EF-5299-4E3C-A30E-6E7BC39076E6

Q24648032-1B858EE2-C616-448C-8374-624435FA3333

Q24648032-1EFFE13E-1F0B-442C-9E34-E463D289BEF4

Q24648032-2772D2F2-0681-40C8-A705-484BCC357705

Q24648032-2E566D55-0599-44BD-930D-CAF3B1ED3DBB

P304

Q24648032-F539C2CA-5827-4531-B90E-E236DFE1B3E0

P31

Q24648032-8C54051F-5249-42AF-8B0F-11F75F452AD6

P3181

Q24648032-5624ACA5-B571-4523-AC79-3D6507C84CE9

P356

Q24648032-8D75DEB7-83F7-48F5-9F42-FE00C99AE21D

P407

Q24648032-264E547D-9119-400F-8213-10E7377D3DE5

P433

Q24648032-053BD586-FE9A-4D26-B1B2-0D8DE271B330

P478

Q24648032-5FAD327B-2D56-41BE-AEB6-F6DA9EA99AED

P50

Q24648032-7839FD8F-313C-41FF-933B-3C7BD779849A

P577

Q24648032-55F302A1-497C-4340-9707-A5ED29BE04B7

P5875

Q24648032-4850B7C8-71C8-4F3A-84B8-1841975F4502

P698

Q24648032-1A831A48-A383-4631-A915-4B61476692BD

P921

Q24648032-65308952-3C0C-41B8-88D5-E05B27DE65A9

P932

Q24648032-C931B44D-10AD-4A3F-A0F6-5FF27AA6D393

P3181

P356

BLOOD-2007-11-120998

P1433

P1476

Tumor-specific Th17-polarized cells eradicate large established melanoma

@en

P2093

Andrea Boni

http://www.w3.org/2001/XMLSchema#string

Andrew Kaiser

http://www.w3.org/2001/XMLSchema#string

Chi-Chao Chan

http://www.w3.org/2001/XMLSchema#string

Christian S Hinrichs

http://www.w3.org/2001/XMLSchema#string

Christopher E Touloukian

http://www.w3.org/2001/XMLSchema#string

Chrystal M Paulos

http://www.w3.org/2001/XMLSchema#string

Claudia Wrzesinski

http://www.w3.org/2001/XMLSchema#string

Kari R Irvine

http://www.w3.org/2001/XMLSchema#string

Keith W Kerstann

http://www.w3.org/2001/XMLSchema#string

Krzysztof Ptak

http://www.w3.org/2001/XMLSchema#string

P2860

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

Requirement for RORgamma in thymocyte survival and lymphoid organ development

Transforming growth factor-beta induces development of the T(H)17 lineage

IL-23 promotes tumour incidence and growth

Interferons, immunity and cancer immunoediting

P304

362-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

654658

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2007-11-120998

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5498499

http://www.w3.org/2001/XMLSchema#string

P698

18354038

http://www.w3.org/2001/XMLSchema#string

P921

P932

2442746

http://www.w3.org/2001/XMLSchema#string